Related Experiment Video

Updated: May 19, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Clinicopathological study of Japanese patients with genetic iron overload syndromes

Ai Hattori1, Hiroaki Miyajima, Naohisa Tomosugi

  • 1Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya, Japan. ai-hat@dpc.agu.ac.jp

Pathology International
|August 29, 2012
PubMed

Insights

Genetic iron overload syndromes like hemochromatosis, aceruloplasminemia, and ferroportin disease present diverse clinicopathological features. This study characterized these features in 16 Japanese patients, revealing genotype-specific iron deposition and diabetes prevalence.

Area of Science:

  • Medical Genetics
  • Hepatology
  • Endocrinology

Background:

  • Genetic iron overload syndromes can cause multi-organ damage.
  • Understanding clinicopathological features across various genetic iron disorders is crucial.

Purpose of the Study:

  • To evaluate clinicopathological features in Japanese patients with genetic iron overload syndromes.
  • To correlate genotypes (CP, HAMP, HJV, TFR2, SLC40A1) with clinical and pathological findings.

Main Methods:

  • Study included 16 Japanese patients with genetic iron overload syndromes.
  • Genotyping for CP, HAMP, HJV, TFR2, and SLC40A1.
  • Analysis of clinical data, liver pathology, transferrin saturation, and serum hepcidin-25 levels.

Main Results:

  • No phenotype dissociation in CP, TFR2, HAMP genotypes. HJV genotype showed classic hemochromatosis. SLC40A1 patients had mild (A) or severe (B) iron overload.
  • Aceruloplasminemia patients had low transferrin saturation. Most patients (except ferroportin disease) had low hepcidin-25.
  • Liver pathology varied by phenotype. Diabetes occurred across aceruloplasminemia, hemochromatosis, and ferroportin disease B.

Conclusions:

  • Clinicopathological features of genetic iron overload syndromes are partially characterized in Japanese patients.
  • Genotype influences iron deposition patterns and disease severity.
  • Diabetes is a common comorbidity across multiple iron overload phenotypes.

More Related Videos

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...